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You See, I See, We All See UC
Katherine M. Joyce MD, MPH; Jody S. Chou BS; Zachary Hanna DO
Henry Ford Health System, Detroit, Michigan
Introduction

Radiology

Pathology

A reported 1.3% of the adult US population carry a diagnosis of Inflammatory Bowel Disease.
(IBD) (1) While the majority of patients suffer from ulcerative colitis or Crohn’s disease, a
significant minority carry a diagnosis of indeterminate colitis. Age (45 or older), race/ethnicity
(Hispanic or non-Hispanic white), education (less than high school diploma), unemployment, US
birth, poverty and living in suburban areas made individuals more likely to report this history.
The increased risk of colorectal cancer (CRC) in ulcerative colitis (UC) is well documented.
Increased risk begins to increase 8-10 years post-diagnosis, although overall incidence in UC
patients has declined significantly since the correlation was first described in 1925. This is likely
due to advances in screening and surveillance. Among those who develop CRC, disease duration
and degree of colitis are most closely correlated, though family history, pseudopolyps, significant
inflammation on histology and primary sclerosing cholangitis also increase a patient’s risk. (2)
Most UC patients who develop CRC do so >10 years after initial diagnosis. Although lymphoma
accounts for <1% of all colon cancers, there is an association between ulcerative colitis and EBVpositive non-Hodgkin’s lymphoma (including diffuse B-cell lymphoma). (3,4) Patients who
develop the disease typically have a history of immunosuppressive therapy, EBV+ lymphocytes
and prolonged IBD. (5) However, not all patients meet these criteria. (5) It is crucial that
neoplastic processes be considered early in the disease course of UC patients, as colorectal nonHodgkin’s lymphoma has been shown to have a 5-year survival rate of <40%. One of the most
aggressive forms, diffuse-B cell lymphoma, has a median survival of approximately two years. (7)

Figure 4 and 5: Sigmoidoscopy biopsy specimens

Discussion
Image 2: Plain abdominal and KUB at time of presentation

Initial colonoscopy was completed as an outpatient at the time of diagnosis, but no further imaging
was completed despite six months of poor response to therapy and development of a mass.
Although CT scan is not required to make a diagnosis of UC, it is possible that earlier recognition
of this patient’s lymphoma could have resulted in improved outcomes. Although bowel perforation
is a known complication in patients undergoing chemotherapy for DBCL, earlier initiation of
chemotherapy prior to the lymphoma eroding the mucosal wall may have prevented his eventual
left-sided colectomy and end-ostomy, which is a significant life-altering procedure. (9)

Toxic megacolon, perforation and acute hemorrhage are the most worrisome emergencies in
patients with UC. Suspicion of such emergencies arise when patients are hemodynamically
unstable and may have findings of air on plain films. Other more insidious processes like
malignancy may require a CT scan to declare themselves.

Patient Presentation
A 21 year old male with history of biopsy-proven ulcerative colitis diagnosed via colonoscopy
(Image 1) six months prior presented to an outside Emergency Department with 5-6 daily episodes of
bloody diarrhea, left sided sharp abdominal pain and abdominal mass with “tightness” over a week.
These symptoms had recently worsened but had persisted since diagnosis. His review of systems
was otherwise negative. Outpatient management with sulfasalazine, balsalazide and prednisone did
not provide relief. He had been making monthly outpatient visits and did not receive further imaging.
In the ED he was afebrile and hemodynamically stable. Physical exam was significant for tenderness
of the left upper and lower quadrants, palpable mass on the left that crossed midline and positive
guaiac test. CBC, BMP, LFT and inflammatory markers were significant for leukocytosis (14.5),
mild normocytic anemia (Hgb 12.6), elevated CRP (2.4) and Sedimentation Rate (45). Abdominal
plain films (Image 2) showed a non-obstructive bowel gas pattern without evidence of colonic
distension. Truelove and Witts score (used for determining UC severity) was mild/severe.(8)
Although initially suspected to be a UC flare, CT revealed significant concentric thickening of the
proximal sigmoid colon up to the entire descending colon and splenic flexure with a masslike lesion
measuring 24 cm x 10 cm intramurally and mildly enlarged pericolonic lymph nodes (Image 3 and 4)
which was concerning for a neoplastic process. Patient was admitted on IV antibiotics with
consideration for ulcerative colitis flare but high suspicion for neoplastic process.

Figure 3 and 4: Abdominal CT at time of presentation

Endoscopic Findings

This patient’s initial ED presentation could have reasonably been considered a moderate UC flare
with disposition for outpatient follow-up based on UC severity indices, labs and plain film that
made perforation or mega-colon unlikely. However, use of CT based on physical exam findings
and patient’s history of symptoms refractory to multiple resulted in almost diagnosis of an
aggressive lymphoma that perforated this patient’s colon less than two weeks later. Although
providers must avoid over-exposing patients to radiation, complications diagnosed by CT are often
serious. In a retrospective review of 354 IBD patients presenting to the ED with new or worsening
GI symptoms, the yield of abdominal CT for clinically actionable findings (eg abscess, tumor,
perforation, obstruction, fistulae, diverticulitis, choledocholithiasis, or appendicitis) was 32.1% for
Crohn’s Disease and 12.8% for UC (p<0.01). (10) CT imaging in the ED or outpatient setting
should be considered due to the seriousness of potential underlying processes.
In contrast, clinical judgement was crucial at the time of the patient’s bowel perforation. This
patient’s abdominal imaging (plain film and CT) showed some evidence of abdominal distension
but perforation was not evident. This case reminds providers that they should not be afraid to rely
on clinical findings despite lack of evidence in radiographic findings.
This case highlights the need to be vigilant in considering UC complications, optimizing imaging
in patients whose UC symptoms are refractive to multiple courses of treatment and the importance
of trusting clinical exam findings despite lack of radiographic evidence.

References
Image 1: Colonoscopy at time of UC diagnosis
(outside facility) showing generalized colitis

Sigmoidoscopy was significant for severe left sided colitis (Mayo Score 3) and a discrete, friable
mass. (Image 5, 6, 7) Biopsy confirmed EBV+ diffuse B-cell lymphoma with a high proliferative
fraction and MYC translocation without Bcl rearrangement. Initial pathology was concerning for
Burkitt lymphoma particularly in the setting of a MYC translocation, though this was eventually
ruled out due to gene expression and morphology. (Figure 4 and 5) Genetic cytology determined that
patient did not possess a double expressor phenotype. Bone marrow aspirate was hypocellular for
age but showed no evidence of dysplasia. CSF was negative for malignant cells.
The patient was initiated on R-EPOCH with plans for possible eventual surgical debulking. On day
13 of his stay, he appeared toxic with acute abdominal pain. Although imaging showed colonic
distension without peritoneal gas, pneumatosis intestinalis or obvious perforation, patient was taken
to the OR emergently based on clinical exam. He was found to have bowel perforation and purulent
peritonitis requiring left colectomy and end-colostomy. He was discharged post-op day nine. REPOCH was resumed two weeks post-op. Several months after initial diagnosis and surgical
intervention, patient maintains an ostomy and is continuing his course of chemotherapy.

Although increased risk of cancer is well documented in UC patients, development of malignancy
is typically not so early in the disease course.

Images 5-7: Sigmoidoscopy at presentation six months
after UC diagnosis. Rectosigmoid junction (5),
sigmoid colon (6) and descending colon (7)

1. Dahlhamer JM, Zammitti EP, Ward BW, Wheaton AG, Croft JB. Prevalence of inflammatory bowel disease among
adults aged ≥18 years—United States, 2015. MMWR Morb Mortal Wkly Rep. 2016;65(42):1166–
1169. https://www.cdc.gov/mmwr/volumes/65/wr/mm6542a3.htm. Accessed April 20, 2020.
2. Lakatos, Peter Laszlo, and Laszlo Lakatos. "Risk for colorectal cancer in ulcerative colitis: changes, causes and
management strategies." World journal of gastroenterology: WJG 14.25 (2008): 3937.
3. Shepherd NA. Pathological mimics of chronic inflammatory bowel disease. J Clin Pathol. 1991;44(9):726–33.
4. Shepherd, N. A., et al. "Primary malignant lymphoma of the colon and rectum. A histopathological and
immunohistochemical analysis of 45 cases with clinicopathological correlations." Histopathology 12.3 (1988): 2352525- Siegel, C. A. (2009). Risk of lymphoma in inflammatory bowel disease. Gastroenterology & hepatology, 5(11),
784.
5. Siegel, C. A. (2009). Risk of lymphoma in inflammatory bowel disease. Gastroenterology & hepatology, 5(11), 784.
6. Mansour, Ramy, et al. "Diffuse Large B-Cell Lymphoma Mimicking an Ulcerative Colitis Flare." ACG Case Reports
Journal 6.3 (2019): 1.
7. Quayle, Frank J., and Jennifer K. Lowney. "Colorectal lymphoma." Clinics in colon and rectal surgery 19.02 (2006):
049-053.
8. Vashist, N. M., Samaan, M., Mosli, M. H., et. al. (2018). Endoscopic scoring indices for evaluation of disease activity in
ulcerative colitis. Cochrane Database of Systematic Reviews, (1).
9. Vonk-Klaassen, Sylvia M., et al. "Ostomy-related problems and their impact on quality of life of colorectal cancer
ostomates: a systematic review." Quality of Life Research 25.1 (2016): 125-133.
10.Yarur et al. Predictive Factors for Clinically Actionable Computed Tomography Findings in Inflammatory Bowel
Disease Patients Seen in the Emergency Department with Acute Gastrointestinal Symptoms. J Crohns Colitis. 2014;8(6):
504-512.

